Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Large-Cell, Anaplastic × avelumab × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Transitional Cell 13 Urinary Bladder Neoplasms 12 Neoplasms 8 Carcinoma, Renal Cell 8 Carcinoma, Merkel Cell 8 Neoplasm Metastasis 7 Breast Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Triple Negative Breast Neoplasms 4 Stomach Neoplasms 4 Ovarian Neoplasms 4 Melanoma 4 Carcinoma, Non-Small-Cell Lung 4 Uterine Cervical Neoplasms 3 Ureteral Neoplasms 3 Skin Neoplasms 3 Prostatic Neoplasms 3 Colorectal Neoplasms 3 Urethral Neoplasms 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Head and Neck Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Hepatocellular 2 Urothelial Cancer 1 Turcot syndrome 1 Thymoma 1 Peritoneal Neoplasms 1 Penile Squamous Cell Carcinoma (PSCC) 1 Penile Neoplasms 1

Interventions

Cyclophosphamide 8 Nivolumab 4 Biopsy 4 fludarabine 3 Specimen Handling 3 Prednisone 3 Magnetic Resonance Spectroscopy 3 Etoposide 3 Doxorubicin 3 Brentuximab Vedotin 3 sodium-iodide symporter 2 pembrolizumab 2 fludarabine phosphate 2 cemiplimab 2 X-Rays 2 Whole-Body Irradiation 2 Vincristine 2 Rituximab 2 Positron-Emission Tomography 2 Photons 2 Mycophenolic Acid 2 Ipilimumab 2 Immunoglobulin G 2 Filgrastim 2 Disulfides 2 Cyclosporine 2 CTLA-4 Antigen 2 10-propargyl-10-deazaaminopterin 2 treosulfan 1 talimogene laherparepvec 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡